Back

PharmaResearch signs MOU with CCM to expand Rejuran Cosmetic in China

Verifying
  • PharmaResearch signed a strategic MOU with CCM to expand Rejuran Cosmetic in China.
  • CCM recorded about 9.178 billion yuan in 2025 revenue, including $1.29 billion.
  • The companies plan localized products and a joint venture structure finalized within the year.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.